Clinical Trial Update: Plerixafor and Granulocyte Colony-stimulating Factor (G-CSF) in Combination With Azacitidine for the Treatment of Myelodysplastic Syndrome (MDS) [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating the combination of plerixafor and G-CSF with azacitidine for myelodysplastic syndromes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Azacitidine (Vidaza) (azacitidine)
• Filgrastim (Neupogen) (filgrastim)
• Plerixafor (Mozobil) (plerixafor)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: COMPLETED